KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Exchange Rate Effect (2016 - 2025)

Merck (MRK) has disclosed Exchange Rate Effect for 17 consecutive years, with $23.0 million as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 106.27% to $23.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $563.0 million through Dec 2025, up 292.15% year-over-year, with the annual reading at $563.0 million for FY2025, 292.15% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $23.0 million at Merck, up from $10.0 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $374.0 million in Q2 2025, with the low at -$412.0 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$12.5 million, with a median of -$50.5 million recorded in 2021.
  • Peak annual rise in Exchange Rate Effect hit 638.24% in 2022, while the deepest fall reached 795.65% in 2022.
  • Over 5 years, Exchange Rate Effect stood at -$68.0 million in 2021, then skyrocketed by 638.24% to $366.0 million in 2022, then crashed by 49.18% to $186.0 million in 2023, then crashed by 297.31% to -$367.0 million in 2024, then soared by 106.27% to $23.0 million in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $23.0 million, $10.0 million, and $374.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.